GLP-1 agonists like Wegovy and Zepbound can help people lose 15-20% of their body weight and improve heart health - but they come with nausea, high costs, and long-term use requirements. Here's what you need to know before starting.
Obesity is a chronic disease driven by biology, not willpower. Learn how metabolic health, genetics, and modern treatments like GLP-1 agonists offer real hope beyond dieting and weight stigma.